Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia

Biology of Blood and Marrow Transplantation

Volumn 4, Issue 1, 1998, Pages 3-12

  Drobyski, William R ^a,d   Pelz, Corey ^a   Kabler Babbitt, Claudia ^a   Hessner, Martin ^b   Baxter Lows, Lee Ann ^c   Keever Taylor, Carolyn A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; Leukemia; Unrelated donors

Indexed keywords

ADULT; AGE; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; HUMAN; MALE; MIDDLE AGED; SURVIVAL;

ADULT; AGE FACTORS; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031615090     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.1998.v4.pm9701386     Document Type: Article

References (40)

1. Clift RA, Storb R: Marrow transplant for CML: the Seattle experience. Bone Marrow Transplant 17 (Suppl 3):S1, 1996.
2. Clift RA, Appelbaum FR, Thomas ED: Treatment of chronic myeloid leukemia by marrow transplantation. Blood 82:1954, 1993.
3. Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A, Masaoka T, McGlave PB, Messner H, O'Reilly RJ, Reiffers J, Rimm AA, Speck B, Veum-Stone JA, Wingard JR, Zwaan FE, Bonis MM: Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 82:2235, 1993.
4. Clift RA, Buckner CD, Thomas ED, Bryant E, Anasetti C, Bensinger WI, Bowden R, Deeg HJ, Doney KC, Fisher LD, Hansen JA, Martin P, McDonald GB, Sanders JE, Schoch G, Singer J, Storb R, Sullivan KM, Witherspoon RP, Appelbaum FR: Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. Blood 84:4368, 1994.
5. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, Van Bekkum DW, Van Rood J, Vowels MR, Zhang M, Horowitz MM: Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 15:1767, 1997.
6. Marks DI, Cullis JD, Ward K, Lacey S, Syzdlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, Batchelor JR, Goldman JM: Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first two years. Ann Int Med 119:207, 1993.
7. Anasetti C, Etzioni R, Petersdorf EW, Martin PJ, Hansen JA: Marrow transplantation from unrelated volunteer donors. Ann Rev Med 46:169, 1995.
8. Kantarjian HM, O'Brien S, Anderlini P, Talpaz M: Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 87:3069, 1996.
9. Gordon-Smith EC, Camilleri-Ferrante C, Donaldson C, Fallowfield L, Gratwoul A, Meadow R, Miles B, Moir DJ, Sackett D, Watts G, Warwick RM: A consensus statement on unrelated donor bone marrow transplantation. Bone Marrow Transplant 19:959, 1997.
10. Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, Pietryga D, Hansen R, Chitambar CR, Anderson T, Flomenberg N: Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 83:1980, 1994.
11. Baxter-Lowe LA, Eckels DD, Ash R, Casper J, Hunter JB, Gorski J: The predictive value of HLA-DR oligotyping for MLC responses. Transplantation 53:1352, 1992.
12. Molkentin J, Gorski J, Baxter-Lowe LA: Detection of 14 HLA-DQB1-alleles by oligotyping. Hum Immunol 31:114, 1991.
13. Yang SF: Population analysis of class I HLA antigens by one dimensional isoelectric focusing gel electrophoresis: workshop summary report. In: B Dupont (ed) Immunobiology of HLA. Vol 1. New York: Springer Verlag, 309, 1989.
14. Keever CA, Leong N, Cunningham I, Cofelan EA, Avalos BR, Klein J, Kapoor N, Adams PW, Orosz CG, Tutscha PJ, Baxter-Lowe LA: HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 14:137, 1994.
15. Szmania S, Keever-Taylor C, Baxter-Lowe LA: Automated nucleotide sequencing reveals substantial disparity between the HLA-A2 genes of bone marrow transplant recipients and donors. Human Immunol 56:77, 1997.
16. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschall JL, Oldham K, Anderson T, Camitta B, Menitove J: Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 322:485, 1990.
17. Waid TH, Lucas BA, Amlot P, Janossy G, Yacoub M, Cammisuli S, Jezek D, Rhoades J, Brown S: T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection. Am J Kidney Dis 14:61, 1989.
18. Glucksberg H, Storb R, Fefer A, Blickner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295, 1974.
19. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MJ, Storb R, Thomas ED: Chronic graft-versus-host syndrome in man: a long term clinicopathologic study of 20 Seattle patients. Am J Med 69:204, 1980.
20. Lind F, Goldman JM, Cross NC: A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukemia. Br J Haematol 86:683, 1994.
21. Hessner MJ, Roth MS, Drobyski WR, Baxter-Lower LA: Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia. Genet Anal Tech Appl 11:90, 1994.
22. Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR: Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86:3987, 1995.
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958.
24. Klein JP, Moeschberger ML: Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer-Verlag, 1997.
25. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993.
26. McGlave P, Kollman C, Shu XO, Anasetti C, Nademanee A, Champlin R, Antin J, Kernan N, King R: The first 1000 unrelated donor transplants for CML: lessons from the National Marrow Donor Program (NMDP) experience. Blood 88:483a, 1996. [abstr]
27. Dini G, Rondelli R, Miano M, Vossen J, Gluckman E, Peters C, Bordigoni P, Locatelli F, Miniero R, Ljungman P, Saarinen U, Klingebiel T, Onega J, Lanino E: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. Bone Marrow Transplant 18 (Suppl 2):80, 1996.
28. Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin P, Mickelson EM, Choo JY, Petersdorf EW, Pepe MS, Appelbaum FR, Bearman SI, Buckner CD, Clift RA, Petersen FB, Singer J, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP, Thomas ED: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 81:249, 1993.
29. Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG, Hansen JA: The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 86:1606, 1995.
30. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW, Appelbaum FR, Buckner CD, Matthews D, Storb R, Sullivan KM, Hansen JA: Unrelated donor marrow transplantation in children. Blood 86:3247, 1995.
31. McGlave PB, Beatty P, Ash R, Hows JM: Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases. Blood 75:1728, 1990.
32. Ash RC, Horowitz MM, Gale RP, Van Bekkum D, Casper JT, Gordon-Smith EC, Henslee PJ, Kolb HJ, Lowenberg B, Masaoka T, McGlave PB, Rimm AA, Ringden O, Van Rood JJ, Sondel PM, Vowels MR, Bortin MM: Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T-cell depletion. Bone Marrow Transplant 7:443, 1991.
33. Butturini A, Seeger RC, Gale RP: Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood 68:954, 1986.
34. Soderling CC, Song CW, Blazar BR, Vallera DA: A correlation between conditioning and engraftment in recipients of MHC-mismatched T-cell depleted murine bone marrow transplants. J Immunol 135:941, 1985.
35. Bozdech MJ, Sondel PM, Trigg ME, Longo W, Kohler PC, Flynn B, Billing R, Anderson SA, Hank JA, Hong R: Transplantation of HLA-haploidentical T-cell depleted marrow for leukemia: Addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. Exp Hematol 13:1201, 1985.
36. Drobyski WR, Endean DJ, Klein JP, Hessner MJ: Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is high-ly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukemia. Br J Haematol 98:458, 1997.
37. Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W: Donor leukocyte infusions for chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood 76:2462, 1990.
38. Porter D, Collins R, Mick R, Kernan N, Giralt S, Flowers M, Casfer J, Drobyski W, Leahey A, Parker P, Bates B, King R, Antin J: Unrelated donor leukocyte infusions to treat relapse or EBV-lymphoproliferative disease after unrelated donor bone marrow transplantation. Blood 90:590a, 1997. [abstr]
39. Small TN, Avigan P, Dupont B, Smith K, Black P, Heller G, Polyak T, O'Reilly RJ: Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant 3:65, 1997.
40. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ: Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73:1340, 1989.